Madrigal Pharmaceuticals Stock Market Value
| MDGL Stock | USD 328.19 3.26 0.98% |
| Symbol | Madrigal |
Madrigal Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Madrigal Pharmaceuticals. If investors know Madrigal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Madrigal Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (25.02) | Revenue Per Share 3.705 | Return On Assets (0.52) | Return On Equity (1.30) |
The market value of Madrigal Pharmaceuticals is measured differently than its book value, which is the value of Madrigal that is recorded on the company's balance sheet. Investors also form their own opinion of Madrigal Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Madrigal Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Madrigal Pharmaceuticals' market value can be influenced by many factors that don't directly affect Madrigal Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Madrigal Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Madrigal Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Madrigal Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Madrigal Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Madrigal Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Madrigal Pharmaceuticals.
| 09/01/2024 |
| 11/30/2024 |
If you would invest 0.00 in Madrigal Pharmaceuticals on September 1, 2024 and sell it all today you would earn a total of 0.00 from holding Madrigal Pharmaceuticals or generate 0.0% return on investment in Madrigal Pharmaceuticals over 90 days. Madrigal Pharmaceuticals is related to or competes with TG Therapeutics, Terns Pharmaceuticals, Hepion Pharmaceuticals, Viking Therapeutics, Sarepta Therapeutics, PTC Therapeutics, and Day One. Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercializa... More
Madrigal Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Madrigal Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Madrigal Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.41 | |||
| Information Ratio | 0.08 | |||
| Maximum Drawdown | 30.27 | |||
| Value At Risk | (3.96) | |||
| Potential Upside | 5.17 |
Madrigal Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Madrigal Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Madrigal Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Madrigal Pharmaceuticals historical prices to predict the future Madrigal Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0926 | |||
| Jensen Alpha | 0.4532 | |||
| Total Risk Alpha | (0.27) | |||
| Sortino Ratio | 0.151 | |||
| Treynor Ratio | 1.61 |
Madrigal Pharmaceuticals Backtested Returns
Madrigal Pharmaceuticals appears to be very steady, given 3 months investment horizon. Madrigal Pharmaceuticals has Sharpe Ratio of 0.13, which conveys that the firm had a 0.13% return per unit of risk over the last 3 months. By analyzing Madrigal Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.62% is justified by implied risk. Please exercise Madrigal Pharmaceuticals' Mean Deviation of 2.7, downside deviation of 2.41, and Risk Adjusted Performance of 0.0926 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Madrigal Pharmaceuticals holds a performance score of 10. The company secures a Beta (Market Risk) of 0.31, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Madrigal Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Madrigal Pharmaceuticals is expected to be smaller as well. Please check Madrigal Pharmaceuticals' downside variance, day median price, and the relationship between the treynor ratio and kurtosis , to make a quick decision on whether Madrigal Pharmaceuticals' current price movements will revert.
Auto-correlation | -0.77 |
Almost perfect reverse predictability
Madrigal Pharmaceuticals has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Madrigal Pharmaceuticals time series from 1st of September 2024 to 16th of October 2024 and 16th of October 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Madrigal Pharmaceuticals price movement. The serial correlation of -0.77 indicates that around 77.0% of current Madrigal Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.77 | |
| Spearman Rank Test | -0.39 | |
| Residual Average | 0.0 | |
| Price Variance | 3282.93 |
Madrigal Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Madrigal Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Madrigal Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Madrigal Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Madrigal Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Madrigal Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Madrigal Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Madrigal Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Madrigal Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Madrigal Pharmaceuticals Lagged Returns
When evaluating Madrigal Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Madrigal Pharmaceuticals stock have on its future price. Madrigal Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Madrigal Pharmaceuticals autocorrelation shows the relationship between Madrigal Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Madrigal Pharmaceuticals.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Madrigal Pharmaceuticals Correlation, Madrigal Pharmaceuticals Volatility and Madrigal Pharmaceuticals Alpha and Beta module to complement your research on Madrigal Pharmaceuticals. For more information on how to buy Madrigal Stock please use our How to buy in Madrigal Stock guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Madrigal Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.